【2025 年 8 月 26 日】 凯莱英医药集团（天津）股份有限公司 2025 年半年度报告全文 1 公司计划不派发现金红利，不送红股，不以公积金转增股本。 2 凯莱英医药集团（天津）股份有限公司 2025 年半年度报告 凯莱英医药集团（天津）股份有限公司 2025 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会及董事、高级管理人员保证半年度报告内容的真实、准确、 完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法 律责任。 公司负责人 HAO HONG、主管会计工作负责人张达及会计机构负责人(会 计主管人员)黄默声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次半年报的董事会会议。 本报告涉及未来计划等前瞻性陈述，同时附有相应的警示性陈述，不构 成公司对投资者的实质承诺，投资者及相关人士均应对此保持足够的风险认 识，并且应该理解计划、预测与承诺之间的差异。 | | 4 | | --- | --- | | œ | 1 2 | | 1 | | | 第一节 | 重要提示、目录和释义 | | 2 | | --- | --- | --- | --- | | ...

Core Insights - The medical services sector experienced a slight increase of 0.18% on August 22, with a net outflow of 494 million yuan in principal funds [1] - Among the constituent stocks, 21 rose while 22 fell, indicating mixed performance within the sector [1] Fund Flow Analysis - The top net outflow stocks included WuXi AppTec with 193 million yuan, Sanbo Brain Science with 162 million yuan, and Kailaiying with approximately 71.53 million yuan [1] - Other notable outflows were observed in Zhaoyan New Drug (52.94 million yuan) and Innovation Medical (44.23 million yuan) [1] Stock Performance - Haocen Medical saw a significant increase of 9.92% with a net inflow of 116 million yuan, representing 19.82% of its market [1] - Baihua Medicine and Dian Diagnostics also reported gains of 1.51% and 2.41%, with net inflows of 414.83 thousand yuan and 393.43 thousand yuan respectively [1] - Conversely, Chengda Pharmaceutical and Guangzheng Eye Care experienced declines of 3.38% and 2.09% respectively, with net outflows of 2149.15 thousand yuan and 1199.08 thousand yuan [1]

港交所消息：8月14日， 花旗集团 公司持有的 凯莱英 （06821.HK）H股多头头寸从9.44%增至 10.21%。 ...

格隆汇8月18日丨根据联交所最新权益披露资料显示，2025年8月13日，凯莱英(06821.HK)获Norges Bank在场内以每股均价94.618港元增持22.1万股，涉资约 2091.06万港元。 增持后，Norges Bank最新持股数目为364.88万股，持股比例由12.44%上升至13.24%。 | 股份代號: | 06821 | | --- | --- | | 上市法國名稱: | 凱萊英醫藥集團(天津)股份有限公司 | | 日期(日 / 月 / 年): | 18/07/2025 - 18/08/2025 | | 表格序號 | 大股東/董事/最高行政人員名 作出披露的 買入 / 賣出或涉及的 每股的平均價 | | | | | 持有權益的股份數目 佔已發行的有關事件的日 相關法 | | --- | --- | --- | --- | --- | --- | --- | | | | | 股份數目 | | | （ 請参関上述 * 註 有投票權股 期 (日 / 月 / | | | | | | | | 份百分比 年) | | CS20250814E00416 | Norges Bank | 1101(L) ...

香港联交所最新数据显示，8月13日，Norges Bank增持凯莱英（002821）(06821)22.1万股，每股作价 94.618港元，总金额约为2091.06万港元。增持后最新持股数目为364.88万股，持股比例为13.24%。 ...

智通财经APP获悉，香港联交所最新数据显示，8月13日，Norges Bank增持凯莱英(06821)22.1万股，每 股作价94.618港元，总金额约为2091.06万港元。增持后最新持股数目为364.88万股，持股比例为 13.24%。 ...

Core Insights - The report highlights significant changes in the Hong Kong Stock Connect holdings, with notable increases and decreases in ownership percentages for various companies [1][2]. Group 1: Increased Holdings - The companies with the largest increases in Hong Kong Stock Connect holdings include: - Hang Seng China Enterprises (02828) with an increase of 6.65%, bringing the total holding to 8.92% [2]. - Tracker Fund of Hong Kong (02800) with an increase of 2.53%, now at 4.89% [2]. - Southern Hang Seng Technology (03033) with an increase of 1.68%, totaling 60.17% [2]. - In the recent five trading days, the largest increases were seen in: - Derun Holdings (01709) with a 7.99% increase, now at 26.35% [3]. - Changfei Optical Fiber (06869) with a 5.86% increase, now at 55.28% [3]. - Chifeng Jilong Gold Mining (06693) with a 3.43% increase, now at 41.14% [3]. Group 2: Decreased Holdings - The companies with the largest decreases in Hong Kong Stock Connect holdings include: - Nanjing Panda Electronics (00553) with a decrease of 1.40%, now at 42.68% [2]. - Dongfang Electric (01072) with a decrease of 1.07%, now at 39.13% [2]. - Dongyang Sunshine Pharmaceutical (06887) with a decrease of 0.99%, now at 49.32% [2]. - In the recent five trading days, the largest decreases were noted in: - Kailai Pharmaceutical (06821) with a decrease of 5.31%, now at 46.07% [3]. - Dongyang Sunshine Pharmaceutical (06887) with a decrease of 3.72%, now at 49.32% [3]. - Ganfeng Lithium (01772) with a decrease of 2.58%, now at 33.34% [3]. Group 3: Long-term Trends - Over the past 20 days, the largest increases in holdings were observed in: - Changfei Optical Fiber (06869) with a 25.54% increase, now at 55.28% [4]. - Dongfang Electric (01072) with an 11.80% increase, now at 39.13% [4]. - The largest decreases over the same period were in: - Marco Digital Technology (01942) with a decrease of 9.72%, now at 42.63% [4]. - Longpan Technology (02465) with a decrease of 6.79%, now at 44.90% [4].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Asymchem Laboratories (Tianjin) Co., Ltd. 凱萊英醫藥集團（天津）股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：6821） 海外監管公告 本海外監管公告乃由本公司根據香港聯合交易所有限公司證券上市規則第13.10B條作出。 茲載列本公司在深圳證券交易所網站刊登的以下資料中文全文，僅供參閱。 承董事會命 於本公告日期，本公司董事會由董事長兼執行董事 Hao Hong 博士，執行董事楊蕊女士 、張達先生及洪亮先生，非執行董事 Ye Song 博士及張婷女士，以及獨立非執行董事孫 雪嬌博士、侯欣一博士及李家聰先生組成。 证券代码：002821 证券简称：凯莱英 公告编号：2025-053 凯莱英医药集团（天津）股份有限公司 关于签署募集资金三方监管协议的公告 凱萊英醫藥集團（天津）股份有限公司 Hao Hong博士 董事長、執行董事兼首席執行官 ...

凯莱英医药集团（天津）股份有限公司 关于签署募集资金三方监管协议的公告 本公司及全体董事会成员保证公告内容真实、准确和完整，不存 在虚假记载、误导性陈述或重大遗漏。 一、募集资金基本情况 经中国证券监督管理委员会《关于核准凯莱英医药集团（天津）股份有限公 司非公开发行股票的批复》（证监许可[2020] 1912号）的核准，凯莱英医药集团 （天津）股份有限公司（以下简称"公司"）非公开发行人民币普通股股票（A股） 10,178,731.00股，每股面值1元，发行价格为227.00元/股，募集资金总额人民 币2,310,571,937.00元，扣除与发行有关的费用人民币35,611,280.94元，公司 实际募集资金净额为人民币2,274,960,656.06元。截至2020年9月23日止，上述 募集资金已全部到账，已经容诚会计师事务所（特殊普通合伙）审验 ，出具了 容诚验字[2020]100Z0073号验资报告。 证券代码：002821 证券简称：凯莱英 公告编号：2025-053 具体募集资金专项账户的开立情况如下： | 序号 | 账户名称 | 开户行名称 | 银行账号 | 募投项目 | | --- | -- ...

Core Insights - The report highlights the changes in the Hong Kong Stock Connect holdings, indicating significant increases and decreases in ownership percentages for various companies [1][2][3][4][5]. Group 1: Increased Holdings - Beijing North Star Industrial Co., Ltd. (00588) saw the largest increase in holdings, up by 1.58%, with a current holding ratio of 43.40% [1] - Fubo Group (03738) and Weimob Inc. (02013) also experienced notable increases of 1.37% and 0.99%, respectively, with holding ratios of 35.89% and 30.88% [1] - Over the last five trading days, Delin Holdings (01709) had the highest increase at 7.63%, bringing its holding ratio to 25.85% [3] - Changfei Optical Fiber Cable (06869) and Haotian International Construction Investment (01341) also saw significant increases of 6.30% and 5.11%, with holding ratios of 53.79% and 57.60% [3] Group 2: Decreased Holdings - Ganfeng Lithium Co., Ltd. (01772) experienced the largest decrease in holdings, down by 3.11%, with a current holding ratio of 33.86% [2] - Longpan Technology (02465) and Southern Hengsheng Technology (03033) also saw decreases of 2.61% and 1.48%, with holding ratios of 43.90% and 58.49% [2] - Over the last five trading days, Yisou Technology (02550) had the most significant decrease at 8.24%, with a holding ratio of 48.23% [3] - Longpan Technology (02465) and Kailai Ying (06821) also faced reductions of 4.48% and 4.45%, with holding ratios of 43.90% and 46.47% [3] Group 3: 20-Day Changes - Over the past 20 days, Changfei Optical Fiber Cable (06869) had the highest increase at 25.23%, with a holding ratio of 53.79% [4] - Other notable increases included Dongfang Electric (01072) and China Energy Construction (03996), with increases of 12.87% and 11.27%, holding ratios of 40.20% and 20.35% respectively [4] - Conversely, Marco Digital Technology (01942) saw the largest decrease at 9.71%, with a holding ratio of 42.65% [5] - Longpan Technology (02465) and Chongqing Steel (01053) also experienced significant decreases of 6.82% and 6.48%, with holding ratios of 43.90% and 33.24% [5]